Ignite Creation Date:
2024-05-06 @ 8:00 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06213636
Status:
RECRUITING
Last Update Posted:
2024-04-09
First Post:
2024-01-10
Brief Title:
Fourth-gen CAR T Cells Targeting CD19CD22 for Highly Resistant B-cell LymphomaLeukemia PMBCLCNS-BCL
Sponsor:
Essen Biotech
Organization:
Essen Biotech
Conditions & Keywords Data
Conditions:
| Name |
|---|
| MCL |
| Acute Lymphoblastic Leukemia Adult B-Cell |
| Acute Lymphoblastic Leukemia in Relapse |
| Non-Hodgkin Lymphoma B-cell |
| Diffuse Large B Cell Lymphoma |
| Central Nervous System Lymphoma |
| Lymphoma Follicular |